Varaico: Literature-Extracted Genetic Variants

Gene:GAA
Variant:p.C103R
Back to variants list

GAA

NM_000152.5:p.C103R

Associated Papers

Genotype-phenotype correlation and CRIM status in Vietnamese children with Pompe disease: a single-center experience.

Nguyen THT et al.

Future Science Oa, 2025

Long-term observation of patients with advanced late-onset Pompe disease undergoing enzyme replacement therapy: A 15-year observation in a single center.

Mori-Yoshimura M et al.

Brain & Development, 2024

Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.

Takahashi J et al.

Journal of Neuromuscular Diseases, 2022

Two Approaches for a Genetic Analysis of Pompe Disease: A Literature Review of Patients with Pompe Disease and Analysis Based on Genomic Data from the General Population.

Park KS

Children (basel, Switzerland), 2021

Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.

Goina E et al.

Human Mutation, 2019

GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

Reuser AJJ et al.

Human Mutation, 2019

31342611 (PubMed )
Supplement: HUMU-40-2146-s001.pdf

Structure of human lysosomal acid α-glucosidase-a guide for the treatment of Pompe disease.

Roig-Zamboni V et al.

Nature Communications, 2017

29061980 (PubMed )
Supplement: 41467_2017_1263_MOESM1_ESM.pdf

Severe Cardiomyopathy as the Isolated Presenting Feature in an Adult with Late-Onset Pompe Disease: A Case Report.

Mori M et al.

Jimd Reports, 2017

Activity of a carboxyl-terminal truncated form of catechol 2,3-dioxygenase from Planococcus sp. S5.

Hupert-Kocurek K et al.

Thescientificworldjournal, 2014

Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants.

Kroos M et al.

Human Mutation, 2012

Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study.

Furusawa Y et al.

Journal of Inherited Metabolic Disease, 2012

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."